RECURSION PHARMACEUTICALS, INC.
SEC 4 · Filed
0001712276-26-000002Accepted
Applies to the EDGAR acceptance time.
Other time zone
Insider transactionsEvent date Mar 17, 2026
- Security
- Class A Common Stock
- Shares
-
7,956
- Price per share
-
3.39
Structured facts
{
"code": "S",
"date": "2026-03-17",
"direction": "D",
"exercise_price": null,
"expiration": null,
"footnotes": {
"F2": "This transaction is pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 30, 2025."
},
"owners": [
{
"cik": "0001712276",
"name": "Taylor Ben R",
"roles": [
"officer"
],
"title": "Chief Financial Officer"
}
],
"ownership": "D",
"post_shares": "1180318",
"price": "3.39",
"row": 2,
"rule_10b5_1": "1",
"security": "Class A Common Stock",
"shares": "7956",
"table": "I",
"underlying_security": null,
"underlying_shares": null
}Insider transactionsEvent date Mar 16, 2026
Payment of exercise price or tax by delivery of securities by Taylor Ben R
- Security
- Class A Common Stock
- Shares
-
7,075
- Price per share
-
3.42
Structured facts
{
"code": "F",
"date": "2026-03-16",
"direction": "D",
"exercise_price": null,
"expiration": null,
"footnotes": {
"F1": "Represents shares that have been withheld by the Issuer to satisfy its tax withholding and remittance obligations in connection with the net settlement of restricted stock units."
},
"owners": [
{
"cik": "0001712276",
"name": "Taylor Ben R",
"roles": [
"officer"
],
"title": "Chief Financial Officer"
}
],
"ownership": "D",
"post_shares": "1188274",
"price": "3.42",
"row": 1,
"rule_10b5_1": "1",
"security": "Class A Common Stock",
"shares": "7075",
"table": "I",
"underlying_security": null,
"underlying_shares": null
}